(19)
(11) EP 3 600 265 A1

(12)

(43) Date of publication:
05.02.2020 Bulletin 2020/06

(21) Application number: 18774366.1

(22) Date of filing: 29.03.2018
(51) International Patent Classification (IPC): 
A61K 9/70(2006.01)
A61P 25/28(2006.01)
C07D 215/18(2006.01)
A61K 31/47(2006.01)
A61P 29/00(2006.01)
(86) International application number:
PCT/CA2018/050389
(87) International publication number:
WO 2018/176149 (04.10.2018 Gazette 2018/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 30.03.2017 US 201762478876 P

(71) Applicant: Intelgenx Corp.
St. Laurent, Québec H4S 1Y2 (CA)

(72) Inventors:
  • PAIEMENT, Nadine
    St-Laurent Québec H4R 3M4 (CA)
  • ZERBE, Horst G.
    Hudson Québec J0P 1J0 (CA)
  • CONWAY, Justin W.
    Carignan Québec J3L 4G7 (CA)
  • OBEID, Rodolphe
    St-Laurent Québec H4L 5P4 (CA)

(74) Representative: Wichmann, Hendrik 
Wuesthoff & Wuesthoff Patentanwälte PartG mbB Schweigerstraße 2
81541 München
81541 München (DE)

   


(54) METHOD OF TREATMENT AND DEVICE FOR THE IMPROVED BIOAVAILABILITY OF LEUKOTRIENE RECEPTOR ANTAGONISTS